283
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Triglyceride Glucose Index Increases Significantly Risk of Hypertension Development in Chinese Individuals Aged ≥45 Years Old: Analysis from the China Health and Retirement Longitudinal Study

ORCID Icon, , , ORCID Icon, , , , & show all
Pages 63-73 | Received 30 Sep 2022, Accepted 07 Jan 2023, Published online: 12 Jan 2023

References

  • Zeng XY, Liu SW, Wang LJ, et al. [Mortality and life expectancy that attributable to high blood pressure in Chinese people in 2013]. Zhonghua Liu xing Bing Xue za zhi. 2017;38(8):1011–1016. Chinese.
  • Lewington S, Lacey B, Clarke R, et al. The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern Med. 2016;176(4):524–532. doi:10.1001/jamainternmed.2016.0190
  • He J, Gu D, Chen J, et al. Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet. 2009;374(9703):1765–1772. doi:10.1016/S0140-6736(09)61199-5
  • Wang Y, Peng X, Nie X, et al. Burden of hypertension in China over the past decades: systematic analysis of prevalence, treatment and control of hypertension. Eur J Prev Cardiol. 2016;23(8):792–800.
  • Murray CJ, Barber RM, Foreman KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145–2191.
  • Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension. 2008;52(5):818–827.
  • Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.
  • Du T, Yuan G, Zhang M, Zhou X, Sun X, Yu X. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance. Cardiovasc Diabetol. 2014;13:146.
  • Ye Z, Xie E, Jiao S, et al. Triglyceride glucose index exacerbates the risk of future cardiovascular disease due to diabetes: evidence from the China Health and Retirement Longitudinal Survey (CHARLS). BMC Cardiovasc Disord. 2022;22(1):236.
  • Wu S, Xu L, Wu M, Chen S, Wang Y, Tian Y. Association between triglyceride-glucose index and risk of arterial stiffness: a cohort study. Cardiovasc Diabetol. 2021;20(1):146. doi:10.1186/s12933-021-01342-2
  • Li M, Zhan A, Huang X, et al. Positive association between triglyceride glucose index and arterial stiffness in hypertensive patients: the China H-type hypertension registry study. Cardiovasc Diabetol. 2020;19(1):139. doi:10.1186/s12933-020-01124-2
  • Hong S, Han K, Park CY. The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. BMC Med. 2020;18(1):361. doi:10.1186/s12916-020-01824-2
  • Kim MK, Ahn CW, Kang S, Nam JS, Kim KR, Park JS. Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults. Cardiovasc Diabetol. 2017;16(1):108. doi:10.1186/s12933-017-0589-4
  • Lee SB, Ahn CW, Lee BK, et al. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc Diabetol. 2018;17(1):41. doi:10.1186/s12933-018-0692-1
  • da Silva A, Caldas APS, Hermsdorff HHM, et al. Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care. Cardiovasc Diabetol. 2019;18(1):89. doi:10.1186/s12933-019-0893-2
  • Arnett DK, Boland LL, Evans GW, et al. Hypertension and arterial stiffness: the atherosclerosis risk in communities study. ARIC investigators. Am J Hypertens. 2000;13(4 Pt 1):317–323. doi:10.1016/S0895-7061(99)00281-2
  • Polipanov AG, Mamasaidov ZA, Geleskhanova YN, Cheskidova NB, Romanova TA, Dzhumagulova AS. [Evaluation of arterial stiffness and possibility to predict carotid atherosclerosis in patients with essential hypertension based on an outpatient facility]. Klin Med. 2016;94(3):211–217. Russian.
  • Pewowaruk RJ, Korcarz C, Tedla Y, et al. Carotid artery stiffness mechanisms associated with cardiovascular disease events and incident hypertension: the multi-ethnic study of atherosclerosis (MESA). Hypertension. 2022;79(3):659–666. doi:10.1161/HYPERTENSIONAHA.121.18772
  • Zheng R, Mao Y. Triglyceride and glucose (TyG) index as a predictor of incident hypertension: a 9-year longitudinal population-based study. Lipids Health Dis. 2017;16(1):175. doi:10.1186/s12944-017-0562-y
  • Jian S, Su-Mei N, Xue C, Jie Z, Xue-Sen W. Association and interaction between triglyceride-glucose index and obesity on risk of hypertension in middle-aged and elderly adults. Clin Exp Hypertens. 2017;39(8):732–739. doi:10.1080/10641963.2017.1324477
  • Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61–68. doi:10.1093/ije/dys203
  • Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens. 2020;38(6):982–1004. doi:10.1097/HJH.0000000000002453
  • Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339
  • Goldman L, Cook EF. The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984;101(6):825–836. doi:10.7326/0003-4819-101-6-825
  • Gregg EW, Cheng YJ, Cadwell BL, et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA. 2005;293(15):1868–1874. doi:10.1001/jama.293.15.1868
  • Chen CL, Liu L, Lo K, et al. Association between triglyceride glucose index and risk of new-onset diabetes among Chinese adults: findings from the China health and retirement longitudinal study. Front Cardiovasc Med. 2020;7:610322. doi:10.3389/fcvm.2020.610322
  • Li H, Zuo Y, Qian F, et al. Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):105. doi:10.1186/s12933-022-01541-5
  • Lytsy P, Ingelsson E, Lind L, Arnlöv J, Sundström J. Interplay of overweight and insulin resistance on hypertension development. J Hypertens. 2014;32(4):834–839. doi:10.1097/HJH.0000000000000081
  • Tack CJ, Smits P, Willemsen JJ, Lenders JW, Thien T, Lutterman JA. Effects of insulin on vascular tone and sympathetic nervous system in NIDDM. Diabetes. 1996;45(1):15–22. doi:10.2337/diab.45.1.15
  • Takagi M, Tanaka Y, Yamasaki Y, et al. Responsiveness of insulin-induced cardiac sympathetic nerve activation associates with blood pressure regulation in diabetics. Am J Physiol Endocrinol Metab. 2003;284(5):E1022–6. doi:10.1152/ajpendo.00169.2002
  • Saitoh S. [Insulin resistance and renin-angiotensin-aldosterone system]. Nihon Rinsho. 2009;67(4):729–734. Japanese.
  • Zemel MB. Insulin resistance vs. hyperinsulinemia in hypertension: insulin regulation of Ca2+ transport and Ca(2+)-regulation of insulin sensitivity. J Nutr. 1995;125(6Suppl):1738s–43s. doi:10.1093/jn/125.suppl_6.1738S
  • Zhao S, Yu S, Chi C, et al. Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai study. Cardiovasc Diabetol. 2019;18(1):95. doi:10.1186/s12933-019-0898-x